DS Healthcare Group (NASDAQ: DSKX) and Unilever PLC (NYSE:UL) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability and institutional ownership.
Institutional and Insider Ownership
8.5% of DS Healthcare Group shares are owned by institutional investors. Comparatively, 7.3% of Unilever PLC shares are owned by institutional investors. 19.4% of DS Healthcare Group shares are owned by insiders. Comparatively, 1.0% of Unilever PLC shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Unilever PLC pays an annual dividend of $1.64 per share and has a dividend yield of 2.7%. DS Healthcare Group does not pay a dividend.
This table compares DS Healthcare Group and Unilever PLC’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|DS Healthcare Group||-104.81%||N/A||-196.55%|
Earnings and Valuation
This table compares DS Healthcare Group and Unilever PLC’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|DS Healthcare Group||N/A||N/A||N/A||($0.77)||-0.02|
|Unilever PLC||$64.79 billion||2.60||$11.58 billion||N/A||N/A|
Unilever PLC has higher revenue and earnings than DS Healthcare Group.
Volatility and Risk
DS Healthcare Group has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, Unilever PLC has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500.
This is a summary of recent recommendations for DS Healthcare Group and Unilever PLC, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|DS Healthcare Group||0||0||0||0||N/A|
Unilever PLC has a consensus price target of $26.00, suggesting a potential downside of 56.55%. Given Unilever PLC’s higher probable upside, analysts plainly believe Unilever PLC is more favorable than DS Healthcare Group.
Unilever PLC beats DS Healthcare Group on 6 of the 8 factors compared between the two stocks.
About DS Healthcare Group
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.
About Unilever PLC
Unilever PLC is a fast-moving consumer goods (FMCG) company. The Company’s segments include Personal Care, which primarily includes sales of skin care and hair care products, deodorants and oral care products; Foods, which primarily includes sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads; Home Care, which primarily includes sales of home care products, such as powders, liquids and capsules, soap bars and a range of cleaning products, and Refreshment, which primarily includes sales of ice cream and tea-based beverages. The Company’s geographical segments include Asia/AMET/RUB, The Americas and Europe. Its brands include Axe, Dirt is Good (Omo), Dove, Family Goodness (Rama), Heartbrand (Wall’s), Hellmann’s, Knorr, Lipton, Lux, Magnum, Rexona, Sunsilk and Surf. The Company operates in more than 100 countries, selling its products in more than 190 countries. The Company operates approximately 310 factories in over 70 countries.
Receive News & Ratings for DS Healthcare Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.